BJP College Seminars Series
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lerner, Y.
Right arrow Articles by Schestatzky, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lerner, Y.
Right arrow Articles by Schestatzky, M.

The British Journal of Psychiatry 153: 359-362 (1988)
© 1988 The Royal College of Psychiatrists

Lithium combined with haloperidol in schizophrenic patients

Y Lerner, Y Mintzer and M Schestatzky
Hadassah Medical School, Hebrew University, Doar Na'Shimshon, Israel.

Previously, the addition of lithium to haloperidol has been reported to be of modest benefit to schizoaffective patients. To test this treatment on a different sample, 36 mainly schizophrenic patients were subdivided on the basis of the median of their initial depression score on the BPRS into depressive and non-depressive schizophrenic subjects. Each group randomly received haloperidol plus placebo or haloperidol plus lithium for 8 weeks. The schizophrenic patients who were on the depressive side of the median BPRS depression score were found to be the most resistant to neuroleptic treatment alone, and benefited from the addition of lithium.


This article has been cited by other articles:


Home page
 Am. J. PsychiatryHome page
S. G. Siris
Depression in Schizophrenia: Perspective in the Era of "Atypical" Antipsychotic Agents
Am J Psychiatry, September 1, 2000; 157(9): 1379 - 1389.
[Abstract] [Full Text]

Home page
 Am. J. PsychiatryHome page
D. F. Levinson, C. Umapathy, and M. Musthaq
Treatment of Schizoaffective Disorder and Schizophrenia With Mood Symptoms
Am J Psychiatry, August 1, 1999; 156(8): 1138 - 1148.
[Abstract] [Full Text]

Home page
 NEJMHome page
R. Michels and P. M. Marzuk
Progress in Psychiatry- First of Two Parts
N. Engl. J. Med., August 19, 1993; 329(8): 552 - 560.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1988 The Royal College of Psychiatrists.